Anebulo Pharmaceuticals (ANEB) Short Interest Ratio & Short Volume → Executive Order To Wipe Out Your Bank Accounts (From Oasis Gold) (Ad) Free ANEB Stock Alerts $2.17 +0.01 (+0.46%) (As of 06/7/2024 08:51 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Anebulo Pharmaceuticals Short Interest DataCurrent Short Interest6,200 sharesPrevious Short Interest17,900 sharesChange Vs. Previous Month-65.36%Dollar Volume Sold Short$14,570.00Short Interest Ratio1.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares25,930,000 sharesFloat Size9,280,000 sharesShort Percent of Float0.07%Today's Trading Volume600 sharesAverage Trading Volume5,349 sharesToday's Volume Vs. Average11% Short Selling Anebulo Pharmaceuticals ? Sign up to receive the latest short interest report for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartANEB Short Interest Over TimeANEB Days to Cover Over TimeANEB Percentage of Float Shorted Over Time Ad Oasis GoldExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now! Anebulo Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20246,200 shares $14,570.00 -65.4%0.1%1.1 $2.35 4/30/202417,900 shares $51,910.00 -11.0%0.2%3.2 $2.90 4/15/202420,100 shares $59,496.00 +6.9%0.2%3.6 $2.96 3/31/202418,800 shares $53,956.00 +308.7%0.2%3.4 $2.87 3/15/20244,600 shares $11,684.00 +39.4%0.1%0.5 $2.54 2/29/20243,300 shares $8,976.00 +10.0%0.0%0.4 $2.72 Get the Latest News and Ratings for ANEB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anebulo Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/20243,000 shares $8,250.00 +11.1%0.0%0.3 $2.75 1/31/20242,700 shares $6,952.50 -18.2%0.1%0.2 $2.58 1/15/20243,300 shares $7,953.00 -10.8%0.2%0.2 $2.41 12/31/20233,700 shares $8,954.00 -14.0%0.2%0.2 $2.42 12/15/20234,300 shares $8,428.00 +30.3%0.2%0.2 $1.96 11/30/20233,300 shares $7,524.00 +32.0%0.2%0.2 $2.28 11/15/20232,500 shares $5,575.00 -56.1%0.1%0.1 $2.23 10/31/20235,700 shares $12,540.00 -52.5%0.3%0.4 $2.20 10/15/202312,000 shares $29,521.20 +55.8%0.4%0.9 $2.46 9/30/20237,700 shares $23,523.50 -44.6%0.3%1.2 $3.06 9/15/202313,900 shares $44,480.00 +1,444.4%0.5%2.2 $3.20 8/31/2023900 shares $2,511.00 -35.7%0.0%0.1 $2.79 8/15/20231,400 shares $4,074.00 -41.7%0.1%0.3 $2.91 7/31/20232,400 shares $5,184.00 -7.7%0.1%0.7 $2.16 7/15/20232,600 shares $6,526.00 +271.4%0.1%0.9 $2.51 6/30/2023700 shares $1,645.00 +40.0%0.0%0.2 $2.35 6/15/2023500 shares $1,125.00 +25.0%0.0%0.1 $2.25 5/31/2023400 shares $904.00 -91.7%0.0%0.1 $2.26 5/15/20234,800 shares $11,160.00 -18.6%0.1%1.4 $2.33 4/30/20235,900 shares $17,228.00 -9.2%0.1%1.6 $2.92 4/15/20236,500 shares $18,135.65 -22.6%0.1%1.4 $2.79 3/31/20238,400 shares $24,360.00 +460.0%0.2%1.6 $2.90 3/15/20231,500 shares $3,765.00 -94.0%0.0%0.3 $2.51 2/28/202324,900 shares $76,692.00 +6.4%0.5%4.3 $3.08 2/15/202323,400 shares $71,634.42 -19.9%0.5%3.6 $3.06 1/31/202329,200 shares $74,460.00 -24.4%0.6%3.8 $2.55 1/15/202338,600 shares $122,744.14 +0.3%0.8%5.4 $3.18 12/30/202238,500 shares $93,312.45 +1.3%0.8%5.1 $2.42 12/15/202238,000 shares $104,880.00 +49.6%0.8%4.5 $2.76 11/30/202225,400 shares $55,880.00 -5.6%0.6%3.3 $2.20 11/15/202226,900 shares $67,788.00 -9.4%0.6%4.1 $2.52 10/31/202229,700 shares $71,577.00 +29.7%1.3%3.1 $2.41 10/15/202222,900 shares $61,830.00 +9.1%1.0%2.3 $2.70 9/30/202221,000 shares $58,800.00 +78.0%0.9%2.1 $2.80Executive Order To Wipe Out Your Bank Accounts (Ad)Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.Click Here To Get Your FREE Guide Now! 9/15/202211,800 shares $44,958.00 +35.6%0.5%0.6 $3.81 8/31/20228,700 shares $30,189.00 -71.7%0.4%0.5 $3.47 8/15/202230,700 shares $117,888.00 +192.4%1.3%1.5 $3.84 7/31/202210,500 shares $31,342.50 -33.1%0.5%0.6 $2.99 7/15/202215,700 shares $48,670.00 -13.7%0.7%1 $3.10 6/30/202218,200 shares $94,640.00 +1,720.0%0.8%1 $5.20 6/15/20221,000 shares $3,170.00 -28.6%0.0%0.1 $3.17 5/31/20221,400 shares $3,780.00 No Change0.1%0.2 $2.70 5/15/20221,400 shares $4,368.00 +250.0%0.1%0.2 $3.12 4/30/2022400 shares $1,484.00 No Change0.0%0.1 $3.71 4/15/2022400 shares $2,184.00 -50.0%0.0%0.1 $5.46 3/31/2022800 shares $5,664.00 -60.0%0.0%0.3 $7.08 3/15/20222,000 shares $13,540.00 -20.0%0.1%1 $6.77 2/28/20222,500 shares $18,225.00 No Change0.1%1.1 $7.29 2/15/20222,500 shares $16,650.25 +13.6%0.1%0.8 $6.66 1/31/20222,200 shares $14,542.00 -35.3%0.1%0.6 $6.61 1/15/20223,400 shares $23,447.08 +41.7%0.2%0.8 $6.90 12/31/20212,400 shares $14,760.00 -22.6%0.1%0.5 $6.15 12/15/20213,100 shares $19,530.00 -54.4%0.1%0.7 $6.30 11/30/20216,800 shares $40,800.00 -2.9%0.3%1.3 $6.00 11/15/20217,000 shares $45,780.00 +16.7%0.3%1.7 $6.54 10/29/20216,000 shares $39,900.00 -35.5%0.3%1.5 $6.65 10/15/20219,300 shares $66,774.00 +66.1%0.4%2.7 $7.18 9/30/20215,600 shares $36,680.00 -34.9%0.2%1.6 $6.55 9/15/20218,600 shares $59,555.00 +59.3%0.4%2.1 $6.93 8/31/20215,400 shares $36,450.00 -21.7%0.2%0.7 $6.75 8/13/20216,900 shares $48,149.58 No Change0.3%0.6 $6.98 ANEB Short Interest - Frequently Asked Questions What is Anebulo Pharmaceuticals' current short interest? Short interest is the volume of Anebulo Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 6,200 shares of ANEB short. 0.07% of Anebulo Pharmaceuticals' shares are currently sold short. Learn More on Anebulo Pharmaceuticals' current short interest. What is a good short interest ratio for Anebulo Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANEB shares currently have a short interest ratio of 1.0. Learn More on Anebulo Pharmaceuticals's short interest ratio. What is a good short interest percentage for Anebulo Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of Anebulo Pharmaceuticals' floating shares are currently sold short. Is Anebulo Pharmaceuticals' short interest increasing or decreasing? Anebulo Pharmaceuticals saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 6,200 shares, a decrease of 65.4% from the previous total of 17,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Anebulo Pharmaceuticals' float size? Anebulo Pharmaceuticals currently has issued a total of 25,933,000 shares. Some of Anebulo Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Anebulo Pharmaceuticals currently has a public float of 9,280,000 shares. How does Anebulo Pharmaceuticals' short interest compare to its competitors? 0.07% of Anebulo Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Anebulo Pharmaceuticals: Sol-Gel Technologies Ltd. (0.11%), Tonix Pharmaceuticals Holding Corp. (0.82%), OptiNose, Inc. (6.45%), Ovid Therapeutics Inc. (4.95%), Generation Bio Co. (3.34%), Prelude Therapeutics Incorporated (2.35%), Omeros Co. (24.44%), Zevra Therapeutics, Inc. (6.45%), Inventiva S.A. (0.13%), Greenwich LifeSciences, Inc. (3.03%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Anebulo Pharmaceuticals stock? Short selling ANEB is an investing strategy that aims to generate trading profit from Anebulo Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Anebulo Pharmaceuticals? A short squeeze for Anebulo Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANEB, which in turn drives the price of the stock up even further. How often is Anebulo Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANEB, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: SLGL Short Interest Data TNXP Short Interest Data OPTN Short Interest Data OVID Short Interest Data GBIO Short Interest Data PRLD Short Interest Data OMER Short Interest Data ZVRA Short Interest Data IVA Short Interest Data GLSI Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ANEB) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anebulo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anebulo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.